ATA261475A - Verfahren zur herstellung von neuen, optisch aktiven oder racemischen 3beta-hydroxy-2- (subst. 1-alkenyl)-5-oxocyclopentan-1-heptansaeuren - Google Patents
Verfahren zur herstellung von neuen, optisch aktiven oder racemischen 3beta-hydroxy-2- (subst. 1-alkenyl)-5-oxocyclopentan-1-heptansaeurenInfo
- Publication number
- ATA261475A ATA261475A AT752614A AT261475A ATA261475A AT A261475 A ATA261475 A AT A261475A AT 752614 A AT752614 A AT 752614A AT 261475 A AT261475 A AT 261475A AT A261475 A ATA261475 A AT A261475A
- Authority
- AT
- Austria
- Prior art keywords
- oxocyclopentan
- heptanic
- 3beta
- subst
- racemic
- Prior art date
Links
- 239000002253 acid Substances 0.000 title 1
- 150000007513 acids Chemical class 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US45879974A | 1974-04-08 | 1974-04-08 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ATA261475A true ATA261475A (de) | 1978-06-15 |
| AT348154B AT348154B (de) | 1979-02-12 |
Family
ID=23822127
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT261475A AT348154B (de) | 1974-04-08 | 1975-04-07 | Verfahren zur herstellung von neuen, optisch aktiven oder racemischen 3beta-hydroxy-2- (subst. 1-alkenyl)-5-oxocyclopentan-1- heptansaeuren |
Country Status (14)
| Country | Link |
|---|---|
| JP (1) | JPS5835183B2 (de) |
| AT (1) | AT348154B (de) |
| BE (1) | BE827694A (de) |
| CA (1) | CA1071625A (de) |
| CH (1) | CH609971A5 (de) |
| DE (1) | DE2515115A1 (de) |
| DK (1) | DK147075A (de) |
| ES (1) | ES436362A1 (de) |
| FR (1) | FR2266500B1 (de) |
| GB (1) | GB1496716A (de) |
| IE (1) | IE41470B1 (de) |
| NL (1) | NL7504104A (de) |
| SE (1) | SE420998B (de) |
| ZA (1) | ZA752183B (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60102774U (ja) * | 1983-12-14 | 1985-07-13 | ソニー株式会社 | フロツピ−デイスクカセツト |
| JPS60106272U (ja) * | 1983-12-24 | 1985-07-19 | ソニー株式会社 | フロツピ−デイスクカセツト |
| JPS60106271U (ja) * | 1983-12-24 | 1985-07-19 | ソニー株式会社 | フロツピ−デイスクカセツト |
| JPS60140266U (ja) * | 1984-02-25 | 1985-09-17 | ソニー株式会社 | 磁気デイスク装置 |
| JPS6121075U (ja) * | 1984-07-07 | 1986-02-06 | ティーディーケイ株式会社 | デイスクカ−トリツジ |
-
1975
- 1975-04-07 DK DK147075A patent/DK147075A/da not_active IP Right Cessation
- 1975-04-07 IE IE767/75A patent/IE41470B1/en unknown
- 1975-04-07 GB GB14093/75A patent/GB1496716A/en not_active Expired
- 1975-04-07 SE SE7503928A patent/SE420998B/xx unknown
- 1975-04-07 ES ES436362A patent/ES436362A1/es not_active Expired
- 1975-04-07 ZA ZA00752183A patent/ZA752183B/xx unknown
- 1975-04-07 NL NL7504104A patent/NL7504104A/xx not_active Application Discontinuation
- 1975-04-07 DE DE19752515115 patent/DE2515115A1/de not_active Withdrawn
- 1975-04-07 AT AT261475A patent/AT348154B/de not_active IP Right Cessation
- 1975-04-07 JP JP50042157A patent/JPS5835183B2/ja not_active Expired
- 1975-04-07 CA CA223,911A patent/CA1071625A/en not_active Expired
- 1975-04-08 CH CH444075A patent/CH609971A5/xx not_active IP Right Cessation
- 1975-04-08 BE BE155198A patent/BE827694A/xx unknown
- 1975-04-08 FR FR7510936A patent/FR2266500B1/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| SE420998B (sv) | 1981-11-16 |
| JPS50137960A (de) | 1975-11-01 |
| ZA752183B (en) | 1976-06-30 |
| JPS5835183B2 (ja) | 1983-08-01 |
| FR2266500B1 (de) | 1978-07-28 |
| ES436362A1 (es) | 1977-01-01 |
| IE41470L (en) | 1975-10-08 |
| DE2515115A1 (de) | 1975-10-16 |
| SE7503928L (sv) | 1975-10-09 |
| BE827694A (fr) | 1975-10-08 |
| AT348154B (de) | 1979-02-12 |
| NL7504104A (nl) | 1975-10-10 |
| AU7990675A (en) | 1976-10-14 |
| CA1071625A (en) | 1980-02-12 |
| FR2266500A1 (de) | 1975-10-31 |
| CH609971A5 (en) | 1979-03-30 |
| DK147075A (de) | 1975-10-09 |
| GB1496716A (en) | 1977-12-30 |
| IE41470B1 (en) | 1980-01-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AT351684B (de) | Verfahren zur herstellung von neuen optisch aktiven oder racemischen verbindungen | |
| AT360974B (de) | Verfahren zur herstellung von neuen optisch aktiven oder racemischen aniliden | |
| AT366030B (de) | Verfahren zur herstellung von neuen carboxyalkylacylaminosaeuren, bzw. deren estern undihren salzen | |
| AT342026B (de) | Verfahren zur herstellung von neuen d,l-n-acyltyrosinamiden | |
| AT360182B (de) | Verfahren zur herstellung von neuen, optisch aktiven und racemischen prostaglandin-derivaten | |
| AT342045B (de) | Verfahren zur herstellung von neuen 1,1-diaryl-1-oxadiazolalkylaminen | |
| AT343631B (de) | Verfahren zur herstellung von racemischem und optisch aktivem threo- und erythro-3-(3,4-dihydroxyphenyl)-serin | |
| AT360673B (de) | Verfahren zur herstellung von neuen optisch aktiven 11-desoxy-16-aryl-omega-prostaglandinen | |
| AT350043B (de) | Verfahren zur herstellung von neuen 3-polyhalogenaethyl-2, 2-dimethylcyclopropan- carbonsaeuren | |
| AT360509B (de) | Verfahren zur herstellung von neuen racemischen oder optisch aktiven aminosaeuren | |
| AT348154B (de) | Verfahren zur herstellung von neuen, optisch aktiven oder racemischen 3beta-hydroxy-2- (subst. 1-alkenyl)-5-oxocyclopentan-1- heptansaeuren | |
| AT341540B (de) | Verfahren zur herstellung von neuen 1,3-dialkyl-7-aminoalkylxanthinen | |
| AT359214B (de) | Verfahren zur herstellung von neuen 9- -hydroxy-19,20-dinorprostanoesaeuren | |
| AT355556B (de) | Verfahren zur herstellung von neuen racemischen oder optisch aktiven threo- oder erythro-1- phenyl-2-n-alkylamino-propandiol-1,3-derivaten | |
| CH552034A (de) | Verfahren zur herstellung von neuen azopigmenten. | |
| AT325599B (de) | Verfahren zur herstellung von neuen, racemischen oder optisch aktiven furanderivaten | |
| AT341669B (de) | Verfahren zur herstellung von neuen 3,4-dicarboxycephalosporinen | |
| AT346505B (de) | Verfahren zur herstellung von neuem racemischem 13beta-aethyl-3-methoxy-8,14-seco- gona-1,3,5 (10), 8-tetraen-17beta-ol-14-on | |
| AT332537B (de) | Verfahren zur herstellung von 6beta-amino-2,2-dimethylpenam-3alfa-carbonsaure | |
| ATA423876A (de) | Verfahren zur herstellung von neuen, racemischen oder optisch aktiven morphinan- derivaten | |
| ATA196973A (de) | Verfahren zur herstellung von neuen 2-amino-4,5-dihydropyridin-3,5-dicarbon | |
| AT316519B (de) | Verfahren zur Herstellung von neuen racemischen bzw. optisch aktiven 6-Hydroxy-6-(3-alkoxy- oder - cycloalkoxy-phenyl)-hexan-3-onen | |
| ATA491379A (de) | Verfahren zur herstellung von neuen 2,9alpha- | |
| AT333254B (de) | Verfahren zur herstellung von neuen racemischen und optisch aktiven aminophenyl-athanolaminen | |
| ATA136975A (de) | Verfahren zur herstellung von neuen racemischen und optisch aktiven aminophenyl-athanolaminen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ELJ | Ceased due to non-payment of the annual fee |